Aspirin Reduces Ventilation And Deaths In Hospitalized COVID-19 Patients
June 15, 2021
...
Jonathan Chow, MD, University, and colleagues concluded that aspirin was useful in keeping people off ventilators and preventing COVID-19 deaths. Here is a summary of their findings.- 412 patients were included in the study
- 314 did not receive aspirin, 98 did.
- The 98 patients who received aspirin were a combination of those who were already taking aspirin before hospitalization and those given it following hospitalization.
- After adjusting for 8 confounders, the use of aspirin was associated with a 44% decrease in ventilation, a 43% decrease in ICU admission, and a 47% decrease in deaths (in the hospital).
- There was no difference in serious bleeding between the two groups.
https://www.medicalnewstoday.com › articles › aspirin-may-reduce-deaths-in-severe-covid-19
After these adjustments, aspirin use was associated with a 43% reduced risk of intensive care unit admission, a 44% reduced risk of mechanical ventilation, and a 47% reduced risk of dying in the...
Aspirin use reduces risk of death in hospitalized COVID-19 ...
https://www.sciencedaily.com › releases › 2020 › 10 › 201022195637.htmThe researchers found aspirin use was associated with a 44 percent reduction in the risk of being put on a mechanical ventilator, a 43 percent decrease in the risk of ICU admission and -- most...
Aspirin may help COVID patients avoid ventilator, lowers ...
https://www.studyfinds.org › aspirin-covid-patients-ventilator-death-riskResults show those who used aspirin had a 44% lower risk of having to be ventilated, as well as a 43% lower risk of ICU admission. Moreover, the mortality rate of those in the hospital was reduced by 47%. Aspirin users and non-aspirin users had no significant variations in severe bleeding or apparent thrombosis.
Aspirin may reduce severe illness or death from COVID ...
https://www.msn.com › en-us › health › medical › aspirin-may-reduce-severe-illness-or-dezath-from-covid-study-says › ar-BB1eLeB5They found aspirin use led to a 44% reduction in the use of ventilators, a 43% reduction in ICU admission and a 47% reduction in in-hospital mortality. © Provided by CBS News Unraveling COVID-19...
Aspirin Reduces Deaths In COVID-19 Patients By 47% | Ray ...
https://raypeatforum.com › community › threads › aspirin-reduces-deaths-in-covid-19-patients-by-47.36984
Aspirin use reduces risk of death in hospitalized COVID-19 patients This study shows that simply talking low dose aspirin 81mg , lowers the risk of dying from covid by 47% . I dont know why this isnt making headlines in the newspapers ... I posted a study that showed an appropriate vitamin D level could reduce mortality by 50%.
https://www.institutefornaturalhealing.com/2021/02/aspirin-lowers-covid-death-risk/
Aspirin Lowers COVID Death Risk
...
But researchers at the University of Maryland found an important added benefit.[3]
Among hospitalized COVID-19 patients, taking daily aspirin was associated with a:
- 44% lower risk of being put on a ventilator
- 43% lower risk of being put in intensive care
- 47% lower risk of death
- The study included 412 COVID-19 patients in four different hospitals on the East Coast. All patients were over 55.
The aspirin users took a dose of 81 mg a day. This is the standard dosage for someone taking aspirin for heart health. They took aspirin as part of their daily routine before they got sick with COVID and continued to do so after they went into the hospital.
One of the World's Oldest Drugs May Combat Its Newest Health Scourge
Dr. Michael A. Mazzeffi co-authored the study. He said aspirin may help COVID patients the same way it prevents heart attacks, by thinning the blood.
...
https://www.christianitydaily.com/articles/13571/20211012/new-research-shows-that-aspirin-reduces-the-chance-of-contracting-covid.htm
New Research Shows Aspirin Reduces Chance Of Contracting COVID, Need For Mechanical Ventilation
OCT 12, 2021
In a recent study from George Washington University, over-the-the-counter aspirin was shown to stabilize the lungs of COVID-19 patients, reducing the need for mechanical ventilation.
According to The Jerusalem Post, the study looked at over 400 COVID patients from hospitals across the country who took aspirin for reasons unrelated to their COVID disease. The team of researchers found that aspirin reduced the likelihood of many endpoints, including mechanical ventilation, ICU hospitalizations, and total in-hospital deaths.
"As we learned about the connection between blood clots and COVID-19, we knew that aspirin - used to prevent stroke and heart attack - could be important for COVID-19 patients," said research team member Dr. Jonathan Chow. "Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death."
Low-dose aspirin is often given to people who have had a heart attack or a myocardial infarction to treat blood clotting issues or reduce their stroke risk, the report said. ARDS, or acute respiratory distress syndrome, is caused by blockages in the pulmonary blood system caused by the coronavirus, which targets the respiratory system.
"Aspirin is low cost, easily accessible and millions are already using it to treat their health conditions," explained Chow. "Finding this association is a huge win for those looking to reduce risk from some of the most devastating effects of COVID-19."
Israeli researchers from the Barzilai Medical Center in March conducted a pilot study where they found comparable outcomes. Apart from preventing blood clots, they discovered that aspirin had immunological advantages and that those who took it had a 29% lower risk of contracting the virus.
Between the first of February and the last day of June of 2020, researchers at the Federation of European Biochemical Societies (FEBS) examined data from around 10,000 Israelis who had their COVID-19 levels checked.
To find out whether a modest dosage of aspirin may help prevent or treat cardiovascular disease, the researchers looked at people who consistently take it vs those who don't take it.
They observed that the first group had a 29% lower risk of contracting the virus than the other.
"This observation of the possible beneficial effect of low doses of aspirin on COVID-19 infection is preliminary but seems very promising," the study's lead author, Prof. Eli Magen of the Barzilai Medical Center, stated in a press statement.
Knowing its well-documented ability to boost the immune system's ability to combat certain viral infections, the researchers chose to test its potential against COVID-19.
According to their findings, those who took aspirin and then became sick recovered quicker than those who didn't, on average, by two or three days. Furthermore, these same individuals tested negative for the virus in a shorter period of time after first testing positive.
Thus, the doctors said that they want to pursue this matter further.
In this research, Dr. Milana Frenkel-Morgenstern of the Azrieli Faculty of Medicine at Bar-Ilan University aimed to better understand the possible beneficial benefits of aspirin in helping the human immune system's fight against COVID-19.
"We intend to investigate a larger cohort of patients and in randomized clinical trials," she said.
Medicines based on acetylsalicylic acid - the active ingredient in aspirin - have been used for years to relieve a variety of symptoms, including pain, fever, and inflammation. The pharmaceutical firm Bayer came up with the term in the late 1800s. Hence, Aspirin became a widely prescribed medication all over the world.
In addition to these two studies, The Blaze claimed that another comparable study has been conducted.
Medical Express reported earlier this month that experts from the University of Minnesota and Basel University in Switzerland had reached the same result.
The results, published in The Lancet's Open Access eClinical Medicine, showed that patients taking blood thinners prior to contracting COVID had lower hospitalization rates despite being older and having more chronic illnesses. Blood thinners, whether taken before or after COVID-19 infection, decreased mortality by almost half.
https://www.jpost.com/health-and-wellness/aspirin-lowers-risk-of-covid-new-findings-support-preliminary-israeli-trial-681127
Aspirin lowers risk of COVID: New findings support preliminary Israeli trial
The treatment reduced the risk of reaching mechanical ventilation by 44%. ICU admissions were lower by 43%, and an overall in-hospital mortality saw a 47% decrease.
...
according to new research at the George Washington University.The team investigated more than 400 COVID patients from hospitals across the United States who take aspirin unrelated to their COVID disease, and found that the treatment reduced the risk of several parameters by almost half: reaching mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%.
...
Israeli researchers reached similar results in a preliminary trial at the Barzilai Medical Center in March. In addition to its effect on blood clots, they found that aspirin carried immunological benefits and that the group taking it was 29% less likely to become infected with the virus in the first place.
No comments:
Post a Comment